BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17632456)

  • 1. Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q.
    Tiemann K; Heitling U; Kosmahl M; Klöppel G
    Mod Pathol; 2007 Sep; 20(9):955-60. PubMed ID: 17632456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid pseudopapillary neoplasms of the pancreas are associated with FLI-1 expression, but not with EWS/FLI-1 translocation.
    Tiemann K; Kosmahl M; Ohlendorf J; Krams M; Klöppel G
    Mod Pathol; 2006 Nov; 19(11):1409-13. PubMed ID: 16941013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of gene expression and activated signaling pathways in solid-pseudopapillary neoplasm of pancreas.
    Park M; Kim M; Hwang D; Park M; Kim WK; Kim SK; Shin J; Park ES; Kang CM; Paik YK; Kim H
    Mod Pathol; 2014 Apr; 27(4):580-93. PubMed ID: 24072181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
    Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
    Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
    Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas.
    Audard V; Cavard C; Richa H; Infante M; Couvelard A; Sauvanet A; Terris B; Paye F; Flejou JF
    Pancreas; 2008 Jan; 36(1):80-3. PubMed ID: 18192886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer.
    Montanaro L; Vici M; Donati G; Ceccarelli C; Santini D; Treré D; Derenzini M
    Histol Histopathol; 2007 Jul; 22(7):769-75. PubMed ID: 17455150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
    Jiang Y; Xie J; Wang B; Mu Y; Liu P
    Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].
    Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S
    Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
    Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
    Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Wnt target genes in solid pseudopapillary tumor of the pancreas: a pilot study.
    Kang CM; Kim HK; Kim H; Choi GH; Kim KS; Choi JS; Lee WJ
    Pancreas; 2009 Mar; 38(2):e53-9. PubMed ID: 19248223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
    Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
    Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated expression of cell cycle-associated proteins in solid pseudopapillary tumor of the pancreas.
    Müller-Höcker J; Zietz CH; Sendelhofert A
    Mod Pathol; 2001 Feb; 14(2):47-53. PubMed ID: 11235905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
    Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
    Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas.
    Cavard C; Audebourg A; Letourneur F; Audard V; Beuvon F; Cagnard N; Radenen B; Varlet P; Vacher-Lavenu MC; Perret C; Terris B
    J Pathol; 2009 Jun; 218(2):201-9. PubMed ID: 19235837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
    Hara A; Saegusa M; Ichinoe M; Okayasu I
    J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.